Antibodies to calnexin and mutated calreticulin are common in human sera
Kyllesbech, C, Trier, N, Mughal, F, Hansen, P, Holmström, M, el Fassi, D, Hasselbalch, H, Skov, V, Kjær, L, Andersen, M, Ciplys, E, Slibinskas, R, Frederiksen, J, Højrup, P, Houen, G
Published in Current research in translational medicine (01.04.2023)
Published in Current research in translational medicine (01.04.2023)
Get full text
Journal Article
Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy
Bukan, KB, Nardo-Marino, A, Hagdrup, C, Boennelycke, M, Breinholdt, MF, Schöllkopf, C, Nielsen, HV, El Fassi, D
Published in Scandinavian journal of rheumatology (04.07.2019)
Published in Scandinavian journal of rheumatology (04.07.2019)
Get full text
Journal Article
Systemic adverse events following rituximab therapy in patients with Graves’ disease
El Fassi, D., Nielsen, C. H., Junker, P., Hasselbalch, H. C., Hegedüs, L.
Published in Journal of endocrinological investigation (01.07.2011)
Published in Journal of endocrinological investigation (01.07.2011)
Get full text
Journal Article
Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease
Fassi, Daniel El, Nielsen, Claus H, Kjeldsen, Jens, Clemmensen, Ole, Hegedüs, Laszlo
Published in Gut (01.05.2008)
Published in Gut (01.05.2008)
Get full text
Journal Article
Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies
El Fassi, Daniel, Banga, J. Paul, Gilbert, Jacqueline A, Padoa, Carolyn, Hegedüs, Laszlo, Nielsen, Claus H
Published in Clinical immunology (Orlando, Fla.) (01.03.2009)
Published in Clinical immunology (Orlando, Fla.) (01.03.2009)
Get full text
Journal Article
PB2210 IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA‐2 OR HYDROXYUREA IN THE DALIAH TRIAL
Patel, D., Knudsen, T. Alma, Hansen, D. Lund, Ocias, L. Frans, Bjerrum, O. Weis, Brabrand, M., Ellervik, C., Fassi, D. el, Frederiksen, M., Kjær, L., Kristensen, T. Kielsgaard, Kruse, O., Mourits‐Andersen, H. T., Møller, P., Overgaard, U. Malthe, Severinsen, M. Tang, Skov, V., Sørensen, A. Lindholm, Stentoft, J., Starklint, J., Stricker, K., Thomassen, M., Larsen, T. Stauffer, Hasselbalch, H. Carl
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
S1609 THREE‐YEAR ANALYSIS OF THE DALIAH TRIAL ‐ A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA‐2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
Knudsen, T.A., Lund Hansen, D., Frans Ocias, L., Weis Bjerrum, O., Brabrand, M., Ellervik, C., Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard, T., Kruse, T. A., Mourits‐Andersen, H. T., Møller, P., Overgaard, U. M., Andersen Patel, D., Tang Severinsen, M., Skov, V., Lindholm Sørensen, A., Stentoft, J., Starklint, J., Stricker, K., Thomassen, M., Stauffer Larsen, T., Hasselbalch, H.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Biological treatment options for Graves' ophthalmopathy
El Fassi, Daniel, Nielsen, Claus Henrik, Hegedüs, Laszlo
Published in Ugeskrift for læger (09.06.2008)
Get more information
Published in Ugeskrift for læger (09.06.2008)
Journal Article
Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy
Bukan, K B, Nardo-Marino, A, Hagdrup, C, Boennelycke, M, Breinholdt, M F, Schöllkopf, C, Nielsen, H V, El Fassi, D
Published in Scandinavian journal of rheumatology (01.07.2019)
Published in Scandinavian journal of rheumatology (01.07.2019)
Get full text
Report